Envestnet Asset Management Inc Myriad Genetics Inc Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 85,378 shares of MYGN stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

85,378

Previous 77,774 9.78%

Holding current value

$1.32 Million

Previous $1.9 Million 22.82%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$23.97 - $28.6 $182,267 - $217,474	7,604 Added 9.78%	85,378 $2.34 Million
Q2 2024 Aug 08, 2024	BUY	$17.98 - $25.47 $176,887 - $250,573	9,838 Added 14.48%	77,774 $1.9 Million
Q1 2024 May 13, 2024	SELL	$17.59 - $23.59 $2.65 Million - $3.56 Million	-150,819 Reduced 68.94%	67,936 $1.45 Million
Q4 2023 Feb 13, 2024	SELL	$13.91 - $21.32 $33,662 - $51,594	-2,420 Reduced 1.09%	218,755 $4.19 Million
Q3 2023 Nov 13, 2023	BUY	$15.99 - $23.22 $1.58 Million - $2.29 Million	98,744 Added 80.65%	221,175 $3.55 Million
Q2 2023 Aug 04, 2023	BUY	$17.56 - $23.76 $93,594 - $126,640	5,330 Added 4.55%	122,431 $2.84 Million
Q1 2023 May 11, 2023	SELL	$15.26 - $23.75 $407,762 - $634,623	-26,721 Reduced 18.58%	117,101 $2.72 Million
Q4 2022 Feb 07, 2023	SELL	$14.51 - $20.99 $152,456 - $220,541	-10,507 Reduced 6.81%	143,822 $2.09 Million
Q3 2022 Nov 10, 2022	BUY	$18.21 - $27.88 $204,461 - $313,036	11,228 Added 7.85%	154,329 $2.95 Million
Q2 2022 Aug 03, 2022	BUY	$16.45 - $25.88 $58,578 - $92,158	3,561 Added 2.55%	143,101 $2.6 Million
Q1 2022 May 04, 2022	BUY	$22.67 - $28.01 $196,548 - $242,846	8,670 Added 6.62%	139,540 $3.52 Million
Q4 2021 Feb 04, 2022	BUY	$24.13 - $32.63 $185,994 - $251,512	7,708 Added 6.26%	130,870 $3.61 Million
Q3 2021 Oct 07, 2021	BUY	$29.97 - $36.66 $357,422 - $437,207	11,926 Added 10.72%	123,162 $3.98 Million
Q2 2021 Aug 04, 2021	SELL	$25.39 - $32.61 $90,540 - $116,287	-3,566 Reduced 3.11%	111,236 $3.4 Million
Q1 2021 May 04, 2021	BUY	$19.92 - $31.6 $422,901 - $670,868	21,230 Added 22.69%	114,802 $3.5 Million
Q4 2020 Feb 02, 2021	BUY	$12.16 - $19.77 $149,312 - $242,755	12,279 Added 15.1%	93,572 $1.85 Million
Q3 2020 Oct 09, 2020	BUY	$11.25 - $14.75 $30,577 - $40,090	2,718 Added 3.46%	81,293 $1.06 Million
Q2 2020 Jul 08, 2020	BUY	$10.69 - $16.49 $229,984 - $354,765	21,514 Added 37.7%	78,575 $891,000
Q1 2020 Apr 23, 2020	BUY	$9.78 - $29.53 $349,380 - $1.05 Million	35,724 Added 167.43%	57,061 $817,000
Q4 2019 Feb 11, 2020	BUY	$20.93 - $35.1 $20,867 - $34,994	997 Added 4.9%	21,337 $581,000
Q3 2019 Oct 17, 2019	BUY	$22.08 - $47.08 $449,107 - $957,607	20,340 New	20,340 $582,000

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.9M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Myriad Genetics Inc Transaction History